Identification of prognosis markers for endometrial cancer by integrated analysis of DNA methylation and RNA-Seq data

被引：31

作者：

Huo, Xiao ^{[1
,2
]}

Sun, Hengzi ^{[1
,2
]}

Cao, Dongyan ^{[1
,2
]}

Yang, Jiaxin ^{[1
,2
]}

Peng, Peng ^{[1
,2
]}

Yu, Mei ^{[1
,2
]}

Shen, Keng ^{[1
,2
]}

机构：

[1] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China

[2] Peking Union Med Coll, Beijing, Peoples R China

来源：

SCIENTIFIC REPORTS | 2019年 / 9卷 / 1期

关键词：

EXPRESSION; DISCOVERY; DIAGNOSIS; PATHWAY; PROTEIN;

D O I：

10.1038/s41598-019-46195-8

中图分类号：

O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];

学科分类号：

07 ; 0710 ; 09 ;

摘要：

Endometrial cancer is highly malignant and has a poor prognosis in the advanced stage, thus, prediction of its prognosis is important. DNA methylation has rapidly gained clinical attention as a biomarker for diagnostic, prognostic and predictive purposes in various cancers. In present study, differentially methylated positions and differentially expressed genes were identified according to DNA methylation and RNA-Seq data. Functional analyses and interaction network were performed to identify hub genes, and overall survival analysis of hub genes were validated. The top genes were evaluated by immunohistochemical staining of endometrial cancer tissues. The gene function was evaluated by cell growth curve after knockdown CDC20 and CCNA2 of endometrial cancer cell line. A total of 329 hypomethylated highly expressed genes and 359 hypermethylated lowly expressed genes were identified, and four hub genes were obtained according to the interaction network. Patients with low expression of CDC20 and CCNA2 showed better overall survival. The results also were demonstrated by the immunohistochemical staining. Cell growth curve also demonstrated that knockdown CDC20 and CCNA2 can suppress the cell proliferation. We have identified two aberrantly methylated genes, CDC20 and CCNA2 as novel biomarkers for precision diagnosis in EC.

引用

页数：10

共 50 条

[31] Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC
Wu, Xiaoqing
Lu, Wenping
Zhang, Weixuan
Zhang, Dongni
Mei, Heting
Zhang, Mengfan
Cui, Yongjia
Zhuo, Zhili
AGING-US, 2023, 15 (21): : 12674 - 12697
[32] Identification of RNA-Seq Gene Fusions in Ovarian Cancer
Hsieh, G.
Szabo, L.
MacLaughlan, S.
Salzman, J.
GYNECOLOGIC ONCOLOGY, 2016, 143 (01) : 218 - 218
[33] Statistical analysis of RNA-seq data at scale
Leek, Jeff T.
GENETIC EPIDEMIOLOGY, 2015, 39 (07) : 563 - 563
[34] A comprehensive review on RNA-seq data analysis
Zhang, Li
Liu, Xuejun
Transactions of Nanjing University of Aeronautics and Astronautics, 2016, 33 (03) : 339 - 361
[35] Dynamic Model for RNA-seq Data Analysis
Li, Lerong
Xiong, Momiao
BIOMED RESEARCH INTERNATIONAL, 2015, 2015
[36] Computational analysis of bacterial RNA-Seq data
McClure, Ryan
Balasubramanian, Divya
Sun, Yan
Bobrovskyy, Maksym
Sumby, Paul
Genco, Caroline A.
Vanderpool, Carin K.
Tjaden, Brian
NUCLEIC ACIDS RESEARCH, 2013, 41 (14)
[37] RseqFlow: workflows for RNA-Seq data analysis
Wang, Ying
Mehta, Gaurang
Mayani, Rajiv
Lu, Jingxi
Souaiaia, Tade
Chen, Yangho
Clark, Andrew
Yoon, Hee Jae
Wan, Lin
Evgrafov, Oleg V.
Knowles, James A.
Deelman, Ewa
Chen, Ting
BIOINFORMATICS, 2011, 27 (18) : 2598 - 2600
[38] A Comprehensive Review on RNA-seq Data Analysis
Zhang Li
Liu Xuejun
Transactions of Nanjing University of Aeronautics and Astronautics, 2016, 33 (03) : 339 - 361
[39] Parametric analysis of RNA-seq expression data
Konishi, Tomokazu
GENES TO CELLS, 2016, 21 (06) : 639 - 647
[40] Integrative Analysis of Bulk RNA-Seq and Single-Cell RNA-Seq Unveils the Characteristics of the Immune Microenvironment and Prognosis Signature in Prostate Cancer
Wang, Ruisong
Xiao, Yaqian
Pan, Meisen
Chen, Zhongyuan
Yang, Pinhong
JOURNAL OF ONCOLOGY, 2022, 2022

← 1 2 3 4 5 →